5 Einträge gefunden

1. Safety and efficacy of elvitegravir, dolutegravir, and raltegravir in a real-world cohort of treatment-naïve and -experienced patients

   1. Brehm, Thomas Theo
   2. Franz, Marleen
   3. Hüfner, Anja
   4. Hertling, Sandra
   5. Schmiedel, Stefan
   6. Degen, Olaf
   7. Kreuels, Benno

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
2. Increased frequency of CD39+ CD56 bright Natural Killer cells in HIV-1 infection correlates with immune activation and disease progression

   1. Dierks, Patrick
   2. Wroblewski, Raluca
   3. Eberhard, Johanna M
   4. Martrus, Gloria
   5. Degen, Olaf
   6. Hertling, Sandra
   7. Schmiedel, Stefan

   2017 - Forschungsinformationssystem des UKE
3. High proportion of HIV late presenters at an academic tertiary care center in northern Germany confirms the results of several cohorts in Germany: time to put better HIV screening efforts on the national agenda?

   1. Schäfer, Guido
   2. Kreuels, Benno
   3. Schmiedel, Stefan
   4. Hertling, Sandra
   5. Hüfner, Anja
   6. Degen, Olaf
   7. Lunzen, Jan

   2016 - Forschungsinformationssystem des UKE
4. German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients

   1. Beisel, Claudia
   2. Heuer, Martin
   3. Otto, Benjamin
   4. Jochum, Johannes
   5. Schmiedel, Stefan
   6. Hertling, Sandra
   7. Degen, Olaf

   2014 - Forschungsinformationssystem des UKE - frei zugänglich
5. Safety and efficacy of protease inhibitor based combination therapy in a single-center "real-life" cohort of 110 patients with chronic hepatitis C genotype 1 infection

   1. Wehmeyer, Malte H
   2. Eißing, Friederike
   3. Jordan, Sabine
   4. Röder, Claudia
   5. Hennigs, Annette
   6. Degen, Olaf
   7. Hüfner, Anja

   2014 - Forschungsinformationssystem des UKE - frei zugänglich